National Drug Code (NDC) Database
Bio-Technology General (Israel) Ltd.
-
NDC:
84606-6824
-
Nonproprietary Name:
Pegloticase
-
Dosage Form:
SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
8 mg/mL
-
Substance:
PEGLOTICASE
-
Start Marketing Date:
2010-12-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
BIOBEAUTECH Co., Ltd.
-
NDC:
83697-010
-
Nonproprietary Name:
Zinc Oxide
-
Dosage Form:
POWDER
-
Product Type:
HUMAN OTC DRUG
-
Strength:
99.99 kg/100kg
-
Substance:
ZINC OXIDE
-
Start Marketing Date:
2023-08-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
BIOBLOOM INC.
-
NDC:
87079-500
-
Nonproprietary Name:
FOXO4-DRI Synthetic Peptide
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
CAT FEL D 1 SYNTHETIC PEPTIDE (CPAVKRDVDLFLT)
-
Start Marketing Date:
2025-09-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
BioChem Oss
-
NDC:
84031-0467
-
Nonproprietary Name:
Heparin Sodium
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
HEPARIN SODIUM
-
Start Marketing Date:
2020-03-17
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Biocon Biologics Limited
-
NDC:
82196-020
-
Nonproprietary Name:
Insulin
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
28.5 mg/g
-
Substance:
INSULIN HUMAN
-
Start Marketing Date:
2024-12-11
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
70383-130
-
Nonproprietary Name:
USTEKINUMAB
-
Dosage Form:
INJECTION, SOLUTION, CONCENTRATE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
5 mg/mL
-
Substance:
USTEKINUMAB
-
Start Marketing Date:
2025-03-03
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
44498-002
-
Nonproprietary Name:
HEPARIN SODIUM
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
HEPARIN SODIUM
-
Start Marketing Date:
2018-12-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Biogen Inc.
-
NDC:
64406-715
-
Nonproprietary Name:
EFANESOCTOCOG ALFA
-
Dosage Form:
POWDER, FOR SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
4000 [iU]/1
-
Substance:
EFANESOCTOCOG ALFA
-
Start Marketing Date:
2023-02-22
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Create a New Buying Request
Fields marked with * are mandatory.